论文部分内容阅读
[目的]探讨核素标记法联合亚甲蓝在早期乳腺癌前哨淋巴结活检中的临床应用价值。[方法]对65例临床确诊的早期乳腺癌患者联合应用99mTc-硫胶体和亚甲蓝标记法进行前哨淋巴结活检,并行腋淋巴结清扫术。[结果]前哨淋巴结活检成功率为100.00%,准确率98.46%,假阴性率6.25%。[结论]核素标记和亚甲蓝联合定位法在前哨淋巴结活检中具有明确的实用性,能有效预测早期乳腺癌腋窝淋巴结转移状况。
[Objective] To explore the clinical value of radionuclide labeling combined with methylene blue in the sentinel lymph node biopsy of early breast cancer. [Method] Sentinel lymph node biopsy and axillary lymph node dissection were performed in 65 patients with clinically diagnosed early stage breast cancer combined with 99mTc-sulfur colloids and methylene blue labeling. [Results] The successful rate of sentinel lymph node biopsy was 100.00%, the accuracy rate was 98.46% and the false negative rate was 6.25%. [Conclusion] The combination of radionuclide labeling and methylene blue scintigraphy has clear practicability in sentinel lymph node biopsy, which can effectively predict the status of axillary lymph node metastasis in early stage of breast cancer.